No abstract available
Keywords:
JAK inhibitor; anemia; myelofibrosis; overall survival; ruxolitinib.
Publication types
-
Letter
-
Randomized Controlled Trial
-
Research Support, N.I.H., Extramural
MeSH terms
-
Aged
-
Anemia / chemically induced
-
Anemia / drug therapy
-
Anemia / etiology*
-
Anemia / mortality*
-
Female
-
Humans
-
Male
-
Nitriles
-
Primary Myelofibrosis / complications*
-
Primary Myelofibrosis / drug therapy
-
Primary Myelofibrosis / mortality
-
Pyrazoles / adverse effects
-
Pyrazoles / therapeutic use*
-
Pyrimidines
Substances
-
Nitriles
-
Pyrazoles
-
Pyrimidines
-
ruxolitinib